American Investment Services Inc. Invests $424,000 in Colgate-Palmolive (CL)

American Investment Services Inc. purchased a new position in Colgate-Palmolive (NYSE:CL) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,188 shares of the company’s stock, valued at approximately $424,000.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc boosted its holdings in Colgate-Palmolive by 1.0% in the third quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock worth $4,922,224,000 after purchasing an additional 734,860 shares during the period. BlackRock Inc. boosted its holdings in Colgate-Palmolive by 13.5% in the fourth quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock worth $3,609,804,000 after purchasing an additional 7,236,342 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Colgate-Palmolive by 3.2% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 32,521,377 shares of the company’s stock worth $1,935,674,000 after purchasing an additional 1,000,161 shares during the period. Northern Trust Corp boosted its holdings in Colgate-Palmolive by 3.0% in the fourth quarter. Northern Trust Corp now owns 10,760,664 shares of the company’s stock worth $640,475,000 after purchasing an additional 309,387 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in Colgate-Palmolive by 7.9% in the fourth quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after purchasing an additional 768,550 shares during the period. Institutional investors and hedge funds own 75.95% of the company’s stock.

A number of research firms have commented on CL. UBS Group lifted their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, March 29th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Tuesday, April 23rd. Jefferies Financial Group boosted their price target on shares of Colgate-Palmolive from $61.00 to $73.00 and gave the company an “in-line” rating in a report on Monday, April 29th. They noted that the move was a valuation call. JPMorgan Chase & Co. raised shares of Colgate-Palmolive from an “underweight” rating to a “neutral” rating and boosted their price target for the company from $62.00 to $70.00 in a report on Monday, April 29th. Finally, ValuEngine raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $69.69.

In related news, CEO Ian M. Cook sold 22,634 shares of the company’s stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total value of $1,500,860.54. Following the completion of the sale, the chief executive officer now owns 1,162,793 shares of the company’s stock, valued at $77,104,803.83. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Justin Skala sold 92,643 shares of the company’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $70.78, for a total transaction of $6,557,271.54. Following the completion of the sale, the vice president now directly owns 163,653 shares of the company’s stock, valued at approximately $11,583,359.34. The disclosure for this sale can be found here. Insiders sold 361,631 shares of company stock valued at $25,382,800 in the last ninety days. Corporate insiders own 1.14% of the company’s stock.

Shares of CL opened at $72.50 on Friday. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $73.10. The firm has a market cap of $61.52 billion, a PE ratio of 24.41, a PEG ratio of 4.69 and a beta of 0.81. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.07 and a quick ratio of 0.74.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.01. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The company had revenue of $3.88 billion during the quarter, compared to the consensus estimate of $3.86 billion. During the same quarter in the previous year, the company posted $0.74 earnings per share. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. On average, analysts anticipate that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were issued a $0.43 dividend. The ex-dividend date of this dividend was Wednesday, April 17th. This represents a $1.72 annualized dividend and a yield of 2.37%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s dividend payout ratio is presently 57.91%.

TRADEMARK VIOLATION WARNING: This report was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.baseballdailydigest.com/news/2019/05/17/american-investment-services-inc-invests-424000-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: Why is a lock-up period needed for an IPO?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.